Q3 FY2026 · ended Sep 30, 2026 · Revenue $1.70B, +4.6% YoY · Filed Oct 28, 2026
Avantor, Inc. (AVTR) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $1.7 billion and net income of $203.4 million. Free cash flow was $156.2 million. As of Sep 30, 2026 it held $464.3 million in cash and investments and $3.7 billion in total debt.
Revenue
$1.70B
+4.6% vs year-ago quarter
Net income
$203.40M
+128.6% vs year-ago quarter
Operating cash flow
$195.10M
-5.9% vs year-ago quarter
Free cash flow
$156.20M
-9.0% vs year-ago quarter
EPS
$0.30
+128.8% vs year-ago quarter
Dividend per share
None
Shares outstanding
677.62M
-0.6% vs year-ago quarter
Net cash
$-3.22B
Q3 FY2026
Operating margin
7.3%
TTM
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- AVTR (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Radnor, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1722482
- Former names
- Vail Holdco Corp (until Dec 28, 2017)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.7B | $1.7B | $1.6B | $1.7B | $1.6B |
| Operating income | $139.5M | $121.8M | $99.5M | $126.4M | -$648.8M |
| Net income | $203.4M | $38.1M | $43.3M | $52.4M | -$711.8M |
| Diluted EPS | $0.30 | $0.06 | $0.06 | $0.08 | -$1.04 |
| Operating cash flow | $195.1M | $178.2M | $58.7M | $152.7M | $207.4M |
| Free cash flow | $156.2M | $140.6M | $25.2M | $117.2M | $171.7M |
| Total assets | $11.6B | $11.6B | $11.7B | $11.8B | $11.7B |
| Total liabilities | $5.8B | $6.0B | $6.1B | $6.2B | $6.1B |
| Stockholders' equity | $5.8B | $5.6B | $5.6B | $5.6B | $5.6B |
| Cash and investments | $464.3M | $306.8M | $279.3M | $365.4M | $251.9M |
| Total debt | $3.7B | $3.7B | $3.8B | $4.2B | $3.9B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Nov 3, 2026 | Oct 30, 2026 |
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 21, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 21, 2026 | Sep 17, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 27, 2026 | Apr 17, 2026 |
All 787 Avantor, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.